A Randomized-controlled Study of a Cognitive-behavioral Intervention for Children With Functional Abdominal Pain
- Conditions
- Abdominal PainFunctional Abdominal Pain Syndrome
- Interventions
- Behavioral: Intervention groupBehavioral: Active control group
- Registration Number
- NCT02030392
- Lead Sponsor
- University of Potsdam
- Brief Summary
This trial aims to compare two training programs for children suffering functional abdominal pain. These two programs are comparable in number of sessions and group sizes, but show differences in content (very focused on pain management vs. more general information and support). Focus of the trial is the evaluation of "Stop the pain", which has shown high effectiveness in one first trial. This time, five clinics, experienced in diagnosis and treatment of childhood chronic abdominal pain, will take part. Children aged 7-12 years are eligible. The programs imply six weekly group sessions for the children and 2 parent evenings. The study group assumes that participation in "Stop the pain" will reduce pain experience and will improve the children's quality of life and coping strategies - up to 12 months after training.
- Detailed Description
The trial aims to assess the efficacy of a cognitive-behavioral self-management program (intervention group, IG) compared to an equally extensive information-only control group (CG). The interventions contain 6 weekly group sessions and 2 parent meetings according to the cognitive-behavioral, manualized program "Stop the pain with Happy Pingu". Follow up per patient: 3- and 12 months. Children aged 7-12 years suffering functional abdominal pain (according to Rome III criteria H2a, H2b, H2d, H2d1) are eligible. Our primary hypothesis is that for patients in the IG the frequency and intensity of pain will be reduced more successfully and more sustainable than for children in the CG. Secondary hypotheses state that the IG will experience a higher increase in quality of life and psychosocial well-being compared to the active CG.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 127
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intervention group Intervention group IG participation in the cognitive-behavioral program "Stop the pain with Happy Pingu". The program compromises six weekly sessions for the children in small groups (90 min each) and 2 sessions for the parents (90 min each). Active control group Active control group CG participation in an information and education control group (physical well-being, health and gastrointestinal tract). The program of the control group compromises six weekly sessions for the children in small groups (90 min each) and 2 sessions for the parents (90 min each).
- Primary Outcome Measures
Name Time Method Change in Pain Symptoms up to 21 days pre intervention, up to 21 days post intervention, 3 month-follow-up, 12 month-follow-up Primary efficacy endpoint is the frequency and intensity of pain (composite score) over the course of treatment and follow-up (pre, post, 3 and 12 months follow-up). This primary outcome will be assessed by pain diary in children's self-report (over 2 weeks).Statistically, the primary endpoint of the study is defined as the change of the logarithm of the area under the pain-intensity curve over one week from start of treatment to 12 month follow-up. The area under the pain intensity curve (auc) is a measure that reflects pain intensity as well as pain duration and pain frequency and thus can be understood as a composite measure of pain.
- Secondary Outcome Measures
Name Time Method Pain-related impairment up to 21 days pre intervention, up to 21 days post intervention, 3 month-follow-up, 12 month-follow-up A measure for child's functional disability due to pain. The measure is one scale score and covers the level of impairment in everyday activitites due to abdominal pain by 12 items, e.g. reading, meeting friends, family life. The secondary outcome variable will be assessed by self-report questionnaire (pre, post, 3- and 12 months follow-up).
Pain-related coping and cognitions up to 21 days pre intervention, up to 21 days post intervention, 3 month-follow-up, 12 month-follow-up The secondary outcome variable will be assessed by self-report questionnaire (pre, post, 3- and 12 months follow-up).
Health-related quality of life up to 21 days pre intervention, up to 21 days post intervention, 3 month-follow-up, 12 month-follow-up The secondary outcome variable will be assessed by self-report questionnaire (pre, post, 3- and 12 months follow-up).
Trial Locations
- Locations (4)
Catholic Children's Hospital Hamburg Wilhelmstift
🇩🇪Hamburg, Germany
University Medical Center, Pediatric Gastroenterology
🇩🇪Ulm, Germany
St. Vincenz Hospital
🇩🇪Paderborn, Germany
Children's Hospital "Prinzessin Margaret", Pediatric Gastroenterology
🇩🇪Darmstadt, Germany